ACPU
PFE icon

Arrowgrass Capital Partners (US)’s Pfizer PFE Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$5.88M Hold
158,100
– – 1.55% 23
2019
Q3 		$5.39M Sell
158,100
-105,400
-40% -$3.83M 0.4% 73
2019
Q2 		$10.8M Hold
263,500
– – 0.26% 109
2019
Q1 		$10.6M Sell
263,500
-31,620
-11% -$1.27M 0.31% 103
2018
Q4 		$12.2M Buy
295,120
+292,169
+9,901% +$12.1M 0.45% 62
2018
Q3 		$12.3M Sell
2,951
-292,169
-99% -$11.2M 0.38% 78
2018
Q2 		$10.2M Buy
+295,120
New +$10.1M 0.35% 80
2018
Q1 		– Sell
-715,455
Closed -$24.6M – 395
2017
Q4 		$24.6M Buy
715,455
+708,300
+9,899% +$24.2M 0.24% 93
2017
Q3 		$24.2M Sell
7,155
-4,848
-40% -$156K 0.18% 138
2017
Q2 		$38.3M Buy
12,003
+429
+4% +$13.5K 0.29% 92
2017
Q1 		$37.6M Buy
11,574
+2,578
+29% +$81.3K 0.39% 64
2016
Q4 		$27.7M Buy
8,996
+2,323
+35% +$70.9K 0.31% 73
2016
Q3 		$21.4M Sell
6,673
-1,019
-13% -$34.1K 0.29% 78
2016
Q2 		$25.7M Buy
7,692
+292
+4% +$9.32K 0.27% 57
2016
Q1 		$20.8M Buy
7,400
+7,009
+1,793% +$200K 0.25% 70
2015
Q4 		$1.2M Sell
391
-2,377
-86% -$74.8K 0.01% 293
2015
Q3 		$8.25M Buy
2,768
+100
+4% +$3.21K 0.15% 112
2015
Q2 		$8.49M Buy
+2,668
New +$87K 0.13% 151

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Arrowgrass Capital Partners (US)'s PFE Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) increased its Pfizer (PFE) stake by 4.6% in Q4 2019, buying an estimated $234K and bringing the position to 149,660 shares worth $5.56M. The position accounts for 1.46% of the portfolio, ranked #25.

Arrowgrass Capital Partners (US) first reported a position in PFE in Q2 2014 and has held it in 17 quarters since. The position peaked at $41M in Q4 2015. 2,525 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Arrowgrass Capital Partners (US) held 149,660 shares of Pfizer worth $5.56M as of Q4 2019.
  • Arrowgrass Capital Partners (US) bought 6,575 Pfizer shares in Q4 2019, an estimated $234K.
  • Pfizer made up 1.46% of Arrowgrass Capital Partners (US)'s portfolio in Q4 2019, its #25 holding.
  • Arrowgrass Capital Partners (US) first reported a position in Pfizer in Q2 2014 and has held it in 17 quarters since.
  • Arrowgrass Capital Partners (US)'s Pfizer position peaked at $41M in Q4 2015.
  • 2,525 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.